About Evergreen Theragnostics
Evergreen Theragnostics is a company based in Jersey City (United States) founded in 2019 was acquired by Lantheus in January 2025.. Evergreen Theragnostics has raised $75.91 million across 4 funding rounds from investors including Lantheus, Liftt and Petrichor. Evergreen Theragnostics offers products and services including CDMO Products and Radiopharmaceuticals. Evergreen Theragnostics operates in a competitive market with competitors including Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and Dotmatics, among others.
- Headquarter Jersey City, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Evergreen Theragnostics, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Evergreen Theragnostics
Evergreen Theragnostics offers a comprehensive portfolio of products and services, including CDMO Products and Radiopharmaceuticals. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Contract development for therapeutic pipelines in healthcare
Products designed to enhance cancer patient options via theragnostics
Unlock access to complete
Leadership Team
1 people
Sales and Marketing
1 people
Microbiology Team
1 people
Legal and Compliance
1 people
Unlock access to complete
Funding Insights of Evergreen Theragnostics
Evergreen Theragnostics has successfully raised a total of $75.91M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $26 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $26.0M
-
First Round
First Round
(27 Apr 2020)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Series C - Evergreen Theragnostics | Valuation |
investors |
|
| Aug, 2023 | Amount | Series B - Evergreen Theragnostics | Valuation |
investors |
|
| Mar, 2023 | Amount | Series B - Evergreen Theragnostics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Evergreen Theragnostics
Evergreen Theragnostics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Lantheus, Liftt and Petrichor. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Petrichor is engaged in supporting healthcare innovation through investments.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Developer of diagnostic imaging agents and targeted therapeutics
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Evergreen Theragnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Evergreen Theragnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Evergreen Theragnostics Comparisons
Competitors of Evergreen Theragnostics
Evergreen Theragnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and Dotmatics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug discovery and development services for small molecules are provided.
|
|
| domain | founded_year | HQ Location |
CDMO services for pharma, biotech, and specialty ingredients are provided.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical products for treating multiple diseases are provided.
|
|
| domain | founded_year | HQ Location |
Generic drugs and clinical research services are provided globally.
|
|
| domain | founded_year | HQ Location |
AI powered scientific data management and workflow automation solutions
|
|
| domain | founded_year | HQ Location |
Laboratory testing, clinical trial research, and biopharma services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Evergreen Theragnostics
Frequently Asked Questions about Evergreen Theragnostics
When was Evergreen Theragnostics founded?
Evergreen Theragnostics was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is Evergreen Theragnostics located?
Evergreen Theragnostics is headquartered in Jersey City, United States. It is registered at Jersey City, New Jersey, United States.
Who is the current CEO of Evergreen Theragnostics?
James Cook is the current CEO of Evergreen Theragnostics.
Is Evergreen Theragnostics a funded company?
Evergreen Theragnostics is a funded company, having raised a total of $75.91M across 4 funding rounds to date. The company's 1st funding round was a Series B of $15M, raised on Apr 27, 2020.
What does Evergreen Theragnostics do?
Evergreen Theragnostics was founded in 2019 and is based in Jersey City, United States. Operations are centered in the radiopharmaceutical sector, where manufacturing of specialized compounds for therapeutic and diagnostic uses is conducted. Regulatory services are offered to ensure compliance with industry standards. The company supports clients in developing and commercializing radiopharmaceutical products, with leadership directed by CEO James Cook. Focus remains on precision medicine applications within biotechnology.
Who are the top competitors of Evergreen Theragnostics?
What products or services does Evergreen Theragnostics offer?
Evergreen Theragnostics offers CDMO Products and Radiopharmaceuticals.